Adegramotide
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Adegramotide
- DrugBank Accession Number
- DB17248
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Synonyms
- Adegrapepimut-s
- Human wilms tumor protein (wt33)-(34-51)-peptide
- L-leucine, l-tryptophyl-l-alanyl-l-prolyl-l-valyl-l-leucyl-l-.alpha.-aspartyl-l-phenylalanyl-l-alanyl-l-prolyl-l-prolylglycyl-l-alanyl-l-seryl-l-alanyl-l-tyrosylglycyl-l-seryl-
- Trp-ala-pro-val-leu-asp-phe-ala-pro-pro-gly-ala-ser-ala-tyr-gly-ser-leu
- External IDs
- DSR-131617
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4XQ7W02EQ0
- CAS number
- 1252802-98-4
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Adegramotide
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Treatment High Grade Glioma: Glioblastoma (GBM) 1 1 Completed Treatment Acute Myeloid Leukemia / Glioblastoma Multiforme (GBM) / Melanoma / Myelodysplastic Syndrome / Non-Small Cell Lung Cancer (NSCLC) / Ovarian Cancer / Pancreatic Cancer / Renal Cell Carcinoma (RCC) / Sarcomas 1 1, 2 Completed Treatment Fallopian Tube Cancer / Platinum-resistant Ovarian Cancer / Primary Peritoneal Cancer / Renal Cell Carcinoma (RCC) / Serous Epithelial Ovarian Cancer / Urothelial Carcinoma 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at November 30, 2022 17:20 / Updated at December 01, 2022 11:36